BT-062

by
Published: Oct 4, 2010 10:23 pm
Brand Name:
Generic Name:
Code Name: BT-062
Company: Biotest
FDA Clinical Phase: 1/2

Description:

BT-062 (news articles) is a toxic drug bound to an antibody that helps deliver the treatment to myeloma and other cancer cells. When the compound enters a cancer cell, it releases the toxic drug that ultimately kills the cell. In a Phase 1 trial, BT-062 demonstrated an acceptable and manageable safety profile as well as evidence of clinical efficacy.

Clinical Trials:
For a list of clinical trials studying BT-062 for the treatment of multiple myeloma, see ClinicalTrials.gov.

Information about BT-062 also is available at the Biotest website.

Tags: ,

Related Articles: